Tumor-targeting molecules, including folate, porphyrins, arginine–glycine–aspartic acid (RGD) peptide, and monoclonal antibody targeting epidermal growth factor receptor (EGFR), have been used to make potential tumor-targeting probes for tumor diagnosis and imaging [15,16,17,18,19]. The gene discussed is EGFR; the disease is neoplasm.